TR200001563T2 - Yapılandırılmış gliseridler kullanarak lipidde çözünebilir bileşiklerin absorpsiyonunu ve taşınmasını artırmak için yöntem. - Google Patents

Yapılandırılmış gliseridler kullanarak lipidde çözünebilir bileşiklerin absorpsiyonunu ve taşınmasını artırmak için yöntem.

Info

Publication number
TR200001563T2
TR200001563T2 TR2000/01563T TR200001563T TR200001563T2 TR 200001563 T2 TR200001563 T2 TR 200001563T2 TR 2000/01563 T TR2000/01563 T TR 2000/01563T TR 200001563 T TR200001563 T TR 200001563T TR 200001563 T2 TR200001563 T2 TR 200001563T2
Authority
TR
Turkey
Prior art keywords
lipid
soluble compounds
transport
increasing absorption
structured
Prior art date
Application number
TR2000/01563T
Other languages
English (en)
Inventor
J. Demichele Stephen
W.Lee Theresa
Tso Patrick
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of TR200001563T2 publication Critical patent/TR200001563T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10—Ester interchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Bu bulus, bir hayvanda, bazi vitaminler, besinler ve ilaçlar gibi lipidde çözünebilen bilesiklerin absorplanmasini tasinmasini artirmak için bir yöntemle ilgilidir. Bu bulusa ait yöntem, bir veya daha fazla lipidde çözünen bilesigin, agirlikça en az %33 kadar 4-12 karbon atomlu bir yag asidi grubu, agirlikça en az %30 kadar 12 den fazla karbon atomuna sahip bir yag asidi grubu ihtiva eden ve 30 dan büyük ancak 48 den küçük bir esdeger karbon sayisina (EKS) sahip yapilandirilmis bir gliserid bileseni esliginde verilmesini içerir. Bu bulus ayrica, bir yapilandirilmis gliserid bileseni ve bir veya daha fazla lipidde çözünebilir bilesik ihtiva eden terkiplerle de ilgilidir. Bu bulusta kulanim için en fazla tercih edilen terkipler, bir hayvana enterik yoldan verilmek için uygundurlar
TR2000/01563T 1997-12-16 1998-12-04 Yapılandırılmış gliseridler kullanarak lipidde çözünebilir bileşiklerin absorpsiyonunu ve taşınmasını artırmak için yöntem. TR200001563T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/991,503 US6013665A (en) 1997-12-16 1997-12-16 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides

Publications (1)

Publication Number Publication Date
TR200001563T2 true TR200001563T2 (tr) 2000-10-23

Family

ID=25537282

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01563T TR200001563T2 (tr) 1997-12-16 1998-12-04 Yapılandırılmış gliseridler kullanarak lipidde çözünebilir bileşiklerin absorpsiyonunu ve taşınmasını artırmak için yöntem.

Country Status (19)

Country Link
US (2) US6013665A (tr)
EP (1) EP1037666B1 (tr)
JP (1) JP2002508336A (tr)
AT (1) ATE250938T1 (tr)
AU (1) AU739233B2 (tr)
BR (1) BR9813474A (tr)
CA (1) CA2315224A1 (tr)
DE (1) DE69818704T2 (tr)
DK (1) DK1037666T3 (tr)
ES (1) ES2209228T3 (tr)
HK (1) HK1032744A1 (tr)
HU (1) HUP0100430A2 (tr)
IL (1) IL135271A0 (tr)
NO (1) NO20002306L (tr)
NZ (1) NZ503666A (tr)
PL (1) PL341208A1 (tr)
PT (1) PT1037666E (tr)
TR (1) TR200001563T2 (tr)
WO (1) WO1999030740A1 (tr)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4198318B2 (ja) * 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
US6835408B2 (en) * 1998-11-13 2004-12-28 The Nisshin Oillio Group, Ltd. Oil or fat composition
US20070244192A1 (en) * 1999-01-14 2007-10-18 Martek Biosciences Corporation Plant seed oils containing polyunsaturated fatty acids
US7247461B2 (en) * 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US7211418B2 (en) * 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR20020038591A (ko) * 1999-06-18 2002-05-23 오노다 마사요시 경구용 의약 조성물
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
IL135335A (en) * 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
KR20020081632A (ko) * 2001-04-19 2002-10-30 (주)라이브맥스 Ｃｌａ가 함유된 재구성 지질의 제조방법 및 이용방법
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
US20030044474A1 (en) * 2001-08-03 2003-03-06 Shaklee Corporation High molecular weight, lipophilic, orally ingestible bioactive agents in formulations having improved bioavailability
JP3980851B2 (ja) * 2001-08-30 2007-09-26 有限会社ゴトーコーポレーション 固型製剤、その製造方法、及び食品
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US7247334B2 (en) * 2002-03-18 2007-07-24 Bunge Oils, Inc. Low-residue, easy-cleaning and low-viscosity structured lipid pan release compositions and methods
US6793959B2 (en) * 2002-03-18 2004-09-21 Bunge Foods Corporation Low viscosity structured lipid pan release compositions and methods
EP1350435B1 (en) * 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US7041840B2 (en) * 2002-12-18 2006-05-09 Alberta Research Council Inc. Antioxidant triacylglycerols and lipid compositions
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20050196434A1 (en) * 2004-03-04 2005-09-08 Brierre Barbara T. Pharmaceutical composition and method for the transdermal delivery of magnesium
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
WO2005105040A2 (en) * 2004-04-26 2005-11-10 Micelle Products, Inc. Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
MX2007004830A (es) * 2004-10-20 2007-10-04 Endorech Inc Precursores esteroides sexuales solos o en combinacion con un modulador receptor de estrogeno selectivo y/o con estrogenos y/o con un inhibidor de fosfodiesterasa gmpc de tipo 5 para la prevencion y tratamiento de resequedad vaginal y disfuncion sexu
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
AU2006236564B2 (en) * 2005-04-15 2011-02-17 Tolmar, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
WO2006113479A2 (en) * 2005-04-15 2006-10-26 Albert Einstein College Of Medicine Of Yeshiva University Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
US20070218183A1 (en) * 2006-03-14 2007-09-20 Bunge Oils, Inc. Oil composition of conjugated linoleic acid
JP2009529891A (ja) * 2006-03-15 2009-08-27 マーテック バイオサイエンシーズ コーポレーション 多価不飽和脂肪酸を含む植物種子油
CA2652314A1 (en) * 2006-05-17 2007-11-22 Ziscoat Nv Fatty acid triglycerides for making biocompatible coatings
US9428582B2 (en) * 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
CA2558202A1 (en) * 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
US8206772B2 (en) * 2007-11-08 2012-06-26 Kraft Foods Global Brands Llc Structured lipid compositions and methods of formulation thereof
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9545117B2 (en) * 2009-02-03 2017-01-17 Tropicana Products, Inc. Microencapsulated citrus phytochemicals and application to beverages
US20100196549A1 (en) * 2009-02-03 2010-08-05 Tropicana Products, Inc. Microencapsulated citrus phytochemicals and application to sports drinks
US20100196554A1 (en) * 2009-02-03 2010-08-05 Tropicana Products, Inc. Microencapsulated citrus phytochemicals comprising citrus limonoids and application to beverages
US20100196577A1 (en) * 2009-02-03 2010-08-05 Tropicana Products, Inc. Microencapsulated citrus phytochemicals comprising citrus limonoids and application to sports drinks
TWI600762B (zh) 2009-03-19 2017-10-01 Ｄｓｍ智慧財產有限公司 多不飽和脂肪酸合成酶核酸分子及多肽，組成物，以及其製造方法與用途
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
TW201121431A (en) * 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
TWI492744B (zh) * 2009-12-04 2015-07-21 Abbott Lab 使用類胡蘿蔔素調節早產兒發炎症之方法
DK2525811T4 (en) * 2010-01-19 2019-04-08 Abbott Lab COMPOSITION, INCLUDING LACTOBACILLUS RHAMNOSUS HN001 AND PREBIOTICS FOR USE IN TREATMENT OF ALLERGIC LUNG DISEASE
WO2011126891A2 (en) * 2010-03-30 2011-10-13 Kraft Foods Global Brands Llc Lipid compositions for increased fatty and creamy mouthfeel and uses thereof
EP2397038A1 (en) 2010-06-21 2011-12-21 Abbott Laboratories Early programming of brain function through soy protein feeding
EP2422629A1 (en) 2010-08-23 2012-02-29 Abbott Laboratories Methods for enhancing cognition and/or memory using maltodextrins
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
MY162797A (en) 2010-12-29 2017-07-14 Abbott Lab Nutritional products including a novel fat system including monoglycerides
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CN110679948A (zh) 2012-12-20 2020-01-14 雅培制药有限公司 使用人乳寡糖用于调节炎症的营养制剂
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US11738087B2 (en) 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
AU2016255966B2 (en) 2015-10-01 2020-04-16 Frieslandcampina Nederland B.V. Liquid nutritional composition comprising micellar casein and hydrolysed whey protein
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
WO2019046491A1 (en) 2017-08-29 2019-03-07 Ariya Therapeutics, Inc. LIPIDIC PRODRUGS DIRECTING TO THE LYMPHATIC SYSTEM
CN111246872A (zh) 2017-10-30 2020-06-05 菲仕兰坎皮纳荷兰公司 治疗和/或预防肌肉质量和/或力量损失相关病症的蛋白质稠密的营养组合物
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID MEDICINAL PRODUCTS AND THEIR USES
WO2020052742A1 (en) * 2018-09-11 2020-03-19 Parapharm Development Limited Capsule, tablet or pill
EP3849551A1 (en) 2018-09-14 2021-07-21 Puretech Lyt 100, Inc. Deuterium-enriched pirfenidone and methods of use thereof
CA3166908A1 (en) 2020-02-05 2021-08-12 Daniel Kenneth BONNER Lipid prodrugs of neurosteroids
EP4132560A1 (en) 2020-04-06 2023-02-15 Abbott Laboratories Nutritional formulations for modulating respiratory-induced cytokines
WO2022177965A1 (en) 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
WO2022226311A1 (en) 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
WO2022266058A1 (en) 2021-06-14 2022-12-22 Abbott Laboratories Methods and compositions for treating gas
WO2023159093A1 (en) 2022-02-16 2023-08-24 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
EP0193602A1 (en) * 1984-09-13 1986-09-10 Center For Nutritional Research Charitable Trust Triglyceride preparations for the prevention of catabolism
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
US5081105A (en) * 1988-01-15 1992-01-14 New England Deaconess Hospital Corporation Method of treating cancer using structured lipids
JP2677613B2 (ja) * 1988-06-24 1997-11-17 エーザイ株式会社 ビタミンｅ又はその誘導体の吸収促進組成物
US5601860A (en) * 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
WO1992019237A1 (en) * 1991-05-08 1992-11-12 Novo Nordisk A/S Use of a lipid for production of a pharmaceutical enteral preparation for treatment of lipid malabsorption
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia

Also Published As

Publication number Publication date
AU739233B2 (en) 2001-10-04
NO20002306L (no) 2000-06-16
HK1032744A1 (en) 2001-08-03
NO20002306D0 (no) 2000-04-28
IL135271A0 (en) 2001-05-20
ATE250938T1 (de) 2003-10-15
PT1037666E (pt) 2004-02-27
NZ503666A (en) 2002-03-01
EP1037666A1 (en) 2000-09-27
DE69818704D1 (de) 2003-11-06
AU1625699A (en) 1999-07-05
CA2315224A1 (en) 1999-06-24
US6160007A (en) 2000-12-12
JP2002508336A (ja) 2002-03-19
BR9813474A (pt) 2000-10-10
PL341208A1 (en) 2001-03-26
WO1999030740A1 (en) 1999-06-24
ES2209228T3 (es) 2004-06-16
HUP0100430A2 (hu) 2001-08-28
US6013665A (en) 2000-01-11
DK1037666T3 (da) 2004-02-09
DE69818704T2 (de) 2004-07-29
EP1037666B1 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
TR200001563T2 (tr) Yapılandırılmış gliseridler kullanarak lipidde çözünebilir bileşiklerin absorpsiyonunu ve taşınmasını artırmak için yöntem.
DK0658097T3 (da) Deodoriserende kosmetiske midler med et indhold af fedtsyrer
NZ301681A (en) composition containing an emulsion comprising fatty acid derivatives and a compound of vegetal origin which can be used to modify the behaviour of cats
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
MX9203026A (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen.
BR9908578A (pt) Composição cosmética
FR2714830B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
PT973413E (pt) Formulacoes nutricionais que contem lacto-n-neotetraose
SE8700423L (sv) Margarinfett
DE3582952D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA953358B (en) New pharmaceutical composition based on taxoids
DE3852358D1 (de) Polyalkoxysilyl-abgeschlossene Polydiorganosiloxane, Verfahren zu ihrer Herstellung und diese enthaltende kaltvulkanisierende Zusammensetzungen.
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
IL92357A0 (en) Pharmaceutical compositions containing an antibacterial compound and an absorption enhancing system
DE69829570D1 (de) Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung
PT87141A (pt) Processo para a preparacao de composicoes de ascomicetos,esquizomicetos e leveduras transformados biofisicamente e de racoes e nutrientes vegetais contendo estas composicoes
DK0904282T3 (da) Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper
DE3683249D1 (de) 2-aminosulfonyl-6-nitrobenzoesaeureester oder amide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9916156A (pt) Método e composição para a manutenção e restituição de integridade do intestino
DE69501183T2 (de) Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung
DE69003569D1 (de) Carbonsaeureester, verfahren zu ihrer herstellung und sie als wirkstoff enthaltende insektizide und/oder acarizide.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
BR9914739A (pt) éster de ácido fosfórico
DE3778826D1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.